Cited by 119Genomics and Chromatin DynamicsChromatin Remodeling and CancerEpigenetics and DNA Methylation

The transcription factor ERG regulates super-enhancers associated with an endothelial-specific gene expression program

Open access
Kalna, Viktoria, Yang, Youwen, Peghaire, Claire R., Frudd, Karen, Hannah, Rebecca, Shah, Aarti V., Osuna Almagro, Lourdes, Boyle, Joseph J. +4 more·2019·Circulation Research

Abstract

Rationale: The ETS (E-26 transformation-specific) transcription factor ERG (ETS-related gene) is essential for endothelial homeostasis, driving expression of lineage genes and repressing proinflammatory genes. Loss of ERG expression is associated with diseases including atherosclerosis. ERG’s homeostatic function is lineage-specific, because aberrant ERG expression in cancer is oncogenic. The molecular basis for ERG lineage-specific activity is unknown. Transcriptional regulation of lineage specificity is linked to enhancer clusters (super-enhancers). Objective: To investigate whether ERG regulates endothelial-specific gene expression via super-enhancers. Methods and Results: Chromatin immunoprecipitation with high-throughput sequencing in human umbilical vein endothelial cells showed that ERG binds 93% of super-enhancers ranked according to H3K27ac, a mark of active chromatin. These were associated with endothelial genes such as DLL4 (Delta-like protein 4), CLDN5 (claudin-5), VWF (von Willebrand factor), and CDH5 (VE-cadherin). Comparison between human umbilical vein endothelial cell and prostate cancer TMPRSS2 (transmembrane protease, serine-2):ERG fusion-positive human prostate epithelial cancer cell line (VCaP) cells revealed distinctive lineage-specific transcriptome and super-enhancer profiles. At a subset of endothelial super-enhancers (including DLL4 and CLDN5), loss of ERG results in significant reduction in gene expression which correlates with decreased enrichment of H3K27ac and MED (Mediator complex subunit)-1, and reduced recruitment of acetyltransferase p300. At these super-enhancers, co-occupancy of GATA2 (GATA-binding protein 2) and AP-1 (activator protein 1) is significantly lower compared with super-enhancers that remained constant following ERG inhibition. These data suggest distinct mechanisms of super-enhancer regulation in endothelial cells and highlight the unique role of ERG in controlling a core subset of super-enhancers. Most disease-associated single nucleotide polymorphisms from genome-wide association studies lie within noncoding regions and perturb transcription factor recognition sequences in relevant cell types. Analysis of genome-wide association studies data shows significant enrichment of risk variants for cardiovascular disease and other diseases, at ERG endothelial enhancers and super-enhancers. Conclusions: The transcription factor ERG promotes endothelial homeostasis via regulation of lineage-specific enhancers and super-enhancers. Enrichment of cardiovascular disease-associated single nucleotide polymorphisms at ERG super-enhancers suggests that ERG-dependent transcription modulates disease risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.118.313788

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genes possibly repressed by SOX9 include endothelial markers VWF and PECAM1, as well as genes encoding TFs important for endothelial cell functions, including ERG and ETS2.

    “Genes possibly repressed by SOX9 include endothelial markers, such as VWF and PECAM1, as well as genes encoding TFs important for endothelial cell functions, including ERG (60) and ETS2 (61).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. [1]Dejana E Hirschi KK Simons M The molecular basis of endothelial cell plasticity Nat Commun 2017 8 14361 PMC5309780 28181491
  2. [2]Shah AV Birdsey GM Randi AM Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG Vascul Pharmacol 2016 86 3 13 27208692 PMC5404112
  3. [3]Vlaeminck-Guillem V Carrere S Dewitte F Stehelin D Desbiens X Duterque-Coquillaud M The ets family member erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis Mech Dev 2000 91 331 335 10704859
  4. [4]Ginsberg M James D Ding BS Nolan D Geng F Butler JM Schachterle W Pulijaal VR Mathew S Chasen ST Xiang J Efficient direct reprogramming of mature amniotic cells into endothelial cells by ets factors and tgfbeta suppression Cell 2012 151 559 575 23084400 PMC3507451
  5. [5]Liu F Patient R Genome-wide analysis of the zebrafish ets family identifies three genes required for hemangioblast differentiation or angiogenesis Circ Res 2008 103 1147 1154 18832752
  6. [6]Birdsey GM Shah AV Dufton N Reynolds LE Osuna Almagro L Yang Y Aspalter IM Khan ST Mason JC Dejana E Gottgens B The endothelial transcription factor erg promotes vascular stability and growth through wnt/beta-catenin signaling Dev Cell 2015 32 82 96 25584796 PMC4292982
  7. [7]Vijayaraj P Le BA Mitchell N Kondo M Juliao S Wasserman M Beeler D Spokes K Aird WC Baldwin HS Oettgen P Erg is a crucial regulator of endocardial-mesenchymal transformation during cardiac valve morphogenesis Development 2012 139 3973 3985 22932696 PMC3472597
  8. [8]Shah AV Birdsey GM Peghaire C Pitulescu ME Dufton N Yang Y Weinberg I Osuna Almagro L Payne L Mason JC Gerhardt H The endothelial transcription factor erg mediates angiopoietin-1-dependent control of notch signalling and vascular stability Nat Commun 2017 8 16002 PMC5508205 28695891
  9. [9]Yuan L Nikolova-Krstevski V Zhan Y Kondo M Bhasin M Varghese L Yano K Carman CV Aird WC Oettgen P Antiinflammatory effects of the ets factor erg in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene Circ Res 2009 104 1049 1057 19359602 PMC3896055
  10. [10]Sperone A Dryden NH Birdsey GM Madden L Johns M Evans PC Mason JC Haskard DO Boyle JJ Paleolog EM Randi AM The transcription factor erg inhibits vascular inflammation by repressing nf-kappab activation and proinflammatory gene expression in endothelial cells Arterioscler Thromb Vasc Biol 2011 31 142 150 20966395
  11. [11]Dufton NP Peghaire CR Osuna-Almagro L Raimondi C Kalna V Chuahan A Webb G Yang Y Birdsey GM Lalor P Mason JC Dynamic regulation of canonical tgfbeta signalling by endothelial transcription factor erg protects from liver fibrogenesis Nat Commun 2017 8 895 PMC5638819 29026072
  12. [12]Hagglof C Hammarsten P Stromvall K Egevad L Josefsson A Stattin P Granfors T Bergh A Tmprss2-erg expression predicts prostate cancer survival and associates with stromal biomarkers PLoS One 2014 9 e86824 24505269 PMC3914792
  13. [13]Tomlins SA Rhodes DR Perner S Dhanasekaran SM Mehra R Sun XW Varambally S Cao X Tchinda J Kuefer R Lee C Recurrent fusion of tmprss2 and ets transcription factor genes in prostate cancer Science 2005 310 644 648 16254181
  14. [14]Adamo P Ladomery MR The oncogene ERG: A key factor in prostate cancer Oncogene 2016 35 4 403 14 25915839
  15. [16]Hogan NT Whalen MB Stolze LK Hadeli NK Lam MT Springstead JR Glass CK Romanoski CE Transcriptional networks specifying homeostatic and inflammatory programs of gene expression in human aortic endothelial cells Elife 2017 6 PMC5461113 28585919
  16. [19]Whyte WA Orlando DA Hnisz D Abraham BJ Lin CY Kagey MH Rahl PB Lee TI Young RA Master transcription factors and mediator establish super-enhancers at key cell identity genes Cell 2013 153 307 319 23582322 PMC3653129
  17. [20]Kaikkonen MU Niskanen H Romanoski CE Kansanen E Kivela AM Laitalainen J Heinz S Benner C Glass CK Yla-Herttuala S Control of vegf-a transcriptional programs by pausing and genomic compartmentalization Nucleic Acids Res 2014 42 12570 12584 25352550 PMC4227755
  18. [21]Brown JD Lin CY Duan Q Griffin G Federation AJ Paranal RM Bair S Newton G Lichtman AH Kung AL Yang T Nf-kappab directs dynamic super enhancer formation in inflammation and atherogenesis Mol Cell 2014 56 219 231 25263595 PMC4224636
  19. [24]Birdsey GM Dryden NH Shah AV Hannah R Hall MD Haskard DO Parsons M Mason JC Zvelebil M Gottgens B Ridley AJ The transcription factor erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis Blood 2012 119 894 903 22117042
  20. [25]ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome Nature 2012 489 57 74 22955616 PMC3439153
  21. [26]Boyle AP Davis S Shulha HP Meltzer P Margulies EH Weng Z Furey TS Crawford GE High-resolution mapping and characterization of open chromatin across the genome Cell 2008 132 311 322 18243105 PMC2669738
  22. [27]Birdsey GM Dryden NH Amsellem V Gebhardt F Sahnan K Haskard DO Dejana E Mason JC Randi AM Transcription factor erg regulates angiogenesis and endothelial apoptosis through ve-cadherin Blood 2008 111 3498 3506 18195090 PMC2275018
  23. [29]Chng KR Chang CW Tan SK Yang C Hong SZ Sng NY Cheung E A transcriptional repressor co-regulatory network governing androgen response in prostate cancers EMBO J 2012 31 2810 2823 22531786 PMC3380210
  24. [30]Yu J Yu J Mani RS Cao Q Brenner CJ Cao X Wang X Wu L Li J Hu M Gong Y An integrated network of androgen receptor, polycomb, and tmprss2-erg gene fusions in prostate cancer progression Cancer Cell 2010 17 443 454 20478527 PMC2874722
  25. [31]Wang S Kollipara RK Srivastava N Li R Ravindranathan P Hernandez E Freeman E Humphries CG Kapur P Lotan Y Fazli L Ablation of the oncogenic transcription factor erg by deubiquitinase inhibition in prostate cancer Proc Natl Acad Sci U S A 2014 111 4251 4256 24591637 PMC3964108
  26. [32]Asangani IA Dommeti VL Wang X Malik R Cieslik M Yang R Escara-Wilke J Wilder-Romans K Dhanireddy S Engelke C Iyer MK Therapeutic targeting of bet bromodomain proteins in castration-resistant prostate cancer Nature 2014 510 278 282 24759320 PMC4075966
  27. [33]Kanki Y Nakaki R Shimamura T Matsunaga T Yamamizu K Katayama S Suehiro JI Osawa T Aburatani H Kodama T Wada Y Dynamically and epigenetically coordinated gata/ets/sox transcription factor expression is indispensable for endothelial cell differentiation Nucleic Acids Res 2017 PMC5416769 28334937
  28. [34]Pomerantz MM Li F Takeda DY Lenci R Chonkar A Chabot M Cejas P Vazquez F Cook J Shivdasani RA Bowden M The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis Nat Genet 2015 47 1346 1351 26457646 PMC4707683
  29. [35]Fish JE Gutierrez MC Dang LT Khyzha N Chen Z Veitch S Cheng HS Khor M Antounians L Njock MS Boudreau E Dynamic regulation of vegf-inducible genes by an erk-erg-p300 transcriptional network Development 2017 144 13 2428 2444 28536097 PMC5536864
  30. [37]Kim BK Im JY Han G Lee WJ Won KJ Chung KS Lee K Ban HS Song K Won M P300 cooperates with c-jun and parp-1 at the p300 binding site to activate rhob transcription in nsc126188-mediated apoptosis Biochim Biophys Acta 2014 1839 364 373 24636898
  31. [38]Pasquali L Gaulton KJ Rodriguez-Segui SA Mularoni L Miguel-Escalada I Akerman I Tena JJ Moran I Gomez-Marin C van de Bunt M Ponsa-Cobas J Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants Nat Genet 2014 46 136 143 24413736 PMC3935450
  32. [39]Mailman MD Feolo M Jin Y Kimura M Tryka K Bagoutdinov R Hao L Kiang A Paschall J Phan L Popova N The ncbi dbgap database of genotypes and phenotypes Nat Genet 2007 39 1181 1186 17898773 PMC2031016
  33. [40]MacArthur J Bowler E Cerezo M Gil L Hall P Hastings E Junkins H McMahon A Milano A Morales J Pendlington ZM The new nhgri-ebi catalog of published genome-wide association studies (gwas catalog) Nucleic Acids Res 2017 45 D896 D901 27899670 PMC5210590
  34. [41]Nagai N Ohguchi H Nakaki R Matsumura Y Kanki Y Sakai J Aburatani H Minami T Downregulation of erg and fli1 expression in endothelial cells triggers endothelial-to-mesenchymal transition PLoS Genet 2018 14 e1007826 30500808 PMC6291168
  35. [42]Madison BJ Clark KA Bhachech N Hollenhorst PC Graves BJ Currie SL Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ets transcription factors and jun-fos at composite DNA sites J Biol Chem 2018 293 18624 18635 30315111 PMC6290139
  36. [43]Vierbuchen T Ling E Cowley CJ Couch CH Wang X Harmin DA Roberts CWM Greenberg ME Ap-1 transcription factors and the baf complex mediate signal-dependent enhancer selection Mol Cell 2017 68 1067 1082 e1012 29272704 PMC5744881
  37. [44]Becker PB Horz W Atp-dependent nucleosome remodeling Annu Rev Biochem 2002 71 247 273 12045097
  38. [45]Sandoval GJ Pulice JL Pakula H Schenone M Takeda DY Pop M Boulay G Williamson KE McBride MJ Pan J Pierre R St Binding of tmprss2-erg to baf chromatin remodeling complexes mediates prostate oncogenesis Mol Cell 2018 71 554 566 e557 30078722 PMC6140332
  39. [46]Miguel-Escalada I Bonàs-Guarch S Cebola I Ponsa-Cobas J Mendieta-Esteban J Rolando DMY Javierre BM Atla G Farabella I Morgan CC García-Hurtado J Human pancreatic islet 3d chromatin architecture provides insights into the genetics of type 2 diabetes bioRxiv 2018 10.1101/400291 PMC6640048 31253982 · DOI
  40. [47]Zaret KS Mango SE Pioneer transcription factors, chromatin dynamics, and cell fate control Curr Opin Genet Dev 2016 37 76 81 26826681 PMC4914445
  41. [48]Jones GT Tromp G Kuivaniemi H Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci Circ Res 2017 120 341 353 27899403 PMC5253231

Cited by

Sorted by citations

Authors
Kalna, V., Yang, Y., Peghaire, C. R., Frudd, K., Hannah, R., Shah, A. V., Osuna Almagro, L., Boyle, J. J., Göttgens, B., Ferrer, J., Randi, A. M., & Birdsey, G. M.
Affiliations
  • Imperial College London (GB)
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
  • From the National Heart and Lung Institute (V.K., Y.Y., C.R.P., K.F., A.V.S., L.O.A., J.J.B., A.M.R., G.M.B.), Imperial College London, United Kingdom
Corresponding author
  • Randi, Anna M.
  • Birdsey, Graeme M.
Venue
Circulation Research
Published
2019-04-26
Volume
124
Issue
9
Pages
1337-1349
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2924079672
Cited by
119
References
7
Citations by year
2026: 12 · 2025: 18 · 2024: 13 · 2023: 21 · 2022: 17 · 2021: 23 · 2020: 11 · 2019: 2
FWCI
4.38
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Circulation Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Wellcome Trust (203151/Z/16/Z)
  • Cancer Research UK (21762)
  • British Heart Foundation (FS/13/12/30037, RG/11/17/29256, PG/17/33/32990, FS/15/65/32036, RG/17/4/32662)
  • Imperial College London
  • Medical Research Council (MC_PC_12009)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
ERG, super-enhancers, ETS transcription factors, H3K27ac, MED1, P300, GATA2, AP-1, DLL4, claudin-5, von Willebrand factor, VE-cadherin, TMPRSS2-ERG fusion, prostate cancer, enhancer regulation
MeSH terms
Transcriptional Regulator ERG, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, Humans, Male, Membrane Proteins, Prostatic Neoplasms, Serine Endopeptidases, Transcription Factor AP-1, Gene Expression Profiling, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, GATA2 Transcription Factor, Human Umbilical Vein Endothelial Cells, Claudin-5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review